Boomerang Ventures

Boomerang Ventures
Menu
STUDIO APPLICATION
FUND APPLICATION
BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.
Learn More

Back to News Page

In the News
In The news

Mentavi Health Unveils AI-backed Mental Health Platform Mentavi Concierge

Source: Digital Health News
Mentavi Health has launched Mentavi Concierge, an AI-powered mental health platform designed to elevate standards of safety, transparency, and clinical oversight in digital care. The system combines advanced conversational AI with licensed clinicians, embedded safety protocols, mood tracking, and human-in-the-loop review to ensure ethical, personalized, and HIPAA-compliant support. CEO Keith Brophy emphasizes that the technology is “patient-lifting, not job-replacing,” reinforcing Mentavi’s commitment to responsible innovation in mental healthcare.

Read More »
11/14/2025
In the News
In The news

Boomerang Ventures Leads $3M Seed in SynchNeuro

Source: Indianapolis Business Journal
Boomerang Ventures has taken the lead in a $3 million seed round for SynchNeuro Inc., a Philadelphia-based health tech startup developing a wearable sensor that translates brainwave activity into real-time health insights. As part of the investment, Boomerang Founder and Managing Partner Oscar Moralez has joined the company’s board, strengthening the partnership as SynchNeuro advances its technology to monitor blood sugar and other critical health metrics.

Read More »
11/14/2025
In the News
In The news

Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro

Source: Tech Point
Boomerang Ventures is backing SynchNeuro’s pioneering effort to build the world’s first brain-based, non-invasive continuous glucose monitor. Using EEG-derived brainwave signals decoded by machine learning, SynchNeuro aims to track blood glucose and cardiometabolic indicators via a discreet wearable placed behind the ear. This seed-stage investment will help speed development of the “Cardiometabolic Advisor” system and bring proactive, needle-free monitoring closer to mass market.

Read More »
11/13/2025
In the News
In The news

Boomerang Ventures Funds Seed-Round for SynchNeuro Wearable

Source: Business Insider
Boomerang Ventures has announced a seed-stage investment in SynchNeuro, a Philadelphia-based startup developing a brain-based, non-invasive wearable sensor to monitor blood glucose and other vital health metrics in real time. The firm’s backing supports SynchNeuro’s mission to use EEG-derived data and machine learning for proactive, needle-free cardiometabolic health insights.

Read More »
11/12/2025
In the News
In The news

Boomerang Ventures Funds Non-Invasive Glucose Startup

Source: Morningstar
Boomerang Ventures has added SynchNeuro, Inc. to its seed-stage portfolio, investing to accelerate development of the world’s first brain-based, non-invasive continuous glucose monitor. The Indianapolis-based fund is backing the startup’s EEG-driven platform that decodes brainwave signals behind the ear to monitor glucose, sleep, stress and cardiometabolic health in real time. “The brain is the richest data source imaginable,” says SynchNeuro founder Dr. Casey Halpern.

Read More »
11/12/2025
Press Release: Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology
Press Releases

Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology

Boomerang Ventures has announced a seed-stage investment in SynchNeuro, a pioneering neurotechnology company developing the world’s first brain-based, non-invasive continuous glucose monitor. The partnership accelerates SynchNeuro’s mission to revolutionize cardiometabolic health through EEG-based technology that interprets brain signals to track blood glucose and other vital metrics in real time. This innovative approach aims to make proactive, pain-free, and affordable glucose monitoring accessible to millions.

Read More »
11/12/2025
In the News
In The news

AI Tools Allow Startups to Drastically Reduce Their Initial Costs

Source: Indianapolis Business Journal
Artificial intelligence is reshaping the startup landscape by drastically cutting costs and reducing the need for large teams or early venture funding. Investors such as Boomerang Ventures’ Tejas Vijh are seeing early-stage companies raise smaller rounds, build faster, and operate leaner as AI transforms both startup creation and venture capital strategy.

Read More »
11/07/2025
In the News
In The news

SiteLabs Secures $2M Seed Led by Boomerang Ventures

Source: Business Insider
Boomerang Ventures has led an oversubscribed seed round totaling $2 million for SiteLabs, a health-tech startup turning independent pharmacies into community-based hubs for preventive diagnostics and clinical research recruitment. With $1 million committed by Boomerang Ventures and additional backing from strategic investors like Labcorp Venture Fund and SC Launch Inc., SiteLabs plans to scale its platform to fuse pharmacy-care, screening and trial-access under one roof.

Read More »
11/06/2025
In the News
In The news

SiteLabs Raises $2M Led by Boomerang Ventures

Source: AP News
Boomerang Ventures, a digital-health studio and fund, led a $2 million oversubscribed seed investment in SiteLabs—a startup transforming independent pharmacies into community hubs for preventive screening, clinical trial access and diagnostics. The round includes strategic backing from Labcorp Venture Fund and SC Launch, positioning SiteLabs to scale rapidly in underserved regions.

Read More »
11/06/2025
In the News
In The news

Boomerang Ventures Leads $2M Seed Round for SiteLabs

Source: Tech Point
“Independent pharmacies are an untapped infrastructure for improving healthcare access in America,” said Darren Schaupp, CEO of SiteLabs. “They know their communities, see patients regularly, and can close critical gaps in preventive care and research recruitment — if we give them the right tools and partnerships.” With its pioneering point-of-care platform, SiteLabs is enabling pharmacies to deliver diagnostic screenings, connect patients to clinical trials, and create new revenue streams while improving health outcomes. Led by Boomerang Ventures, SiteLabs just closed a $2 million seed round to transform neighborhood pharmacies into frontline hubs for preventive care and research participation.

Read More »
11/03/2025

Back to News Page

Boomerang Ventures
Loading...